e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome
Pelletier-Fleury N., Meslier N., Gagnadoux F., Person C., Rakotonanahary D., Ouksel H., Fleury B., Racineux J-L.
Source:
Eur Respir J 2004; 23: 53-60
Journal Issue:
January
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pelletier-Fleury N., Meslier N., Gagnadoux F., Person C., Rakotonanahary D., Ouksel H., Fleury B., Racineux J-L.. Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome. Eur Respir J 2004; 23: 53-60
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Compliance in sleep apnoea therapy: influence of home care support and pressure mode
Source: Eur Respir J 2009; 33: 804-811
Year: 2009
Management of continuous positive airway pressure treatment compliance using telemonitoring in obstructive sleep apnoea
Source: Eur Respir J , 49 (2) 1601128; DOI: 10.1183/13993003.01128-2016
Year: 2017
Tele-monitoring system implementation in continuous positive airway pressure therapy in Asian obstructive sleep apnea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Are symptoms of obstructive sleep apnoea related to good continuous positive airway pressure compliance?
Source: ERJ Open Res, 6 (3) 00169-2019; 10.1183/23120541.00169-2019
Year: 2020
Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome
Source: International Congress 2017 – Inhalers and their use
Year: 2017
The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea
Source: Eur Respir J 2003; 21: 515-522
Year: 2003
Ventilatory management in COPD-associated obstructive sleep apnea syndrome
Source: International Congress 2015 – Novelties in noninvasive ventilation
Year: 2015
Prescription, subjective and objective compliances in patients with obstructive sleep apnea syndrome using positive airway pressure
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Index for comfort of patients with obstructive sleep apnea on continuous positive airway pressure therapy
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Eur Respir J 2013; 41: 523-538
Year: 2013
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
Telehealthcare interventions in the management of obstructive sleep apnoea hypopnoea syndrome (OSAHS) in continuous positive airway pressure (CPAP) users - A systematic review
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Impact of CPAP on asthmatic patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 29: 307-311
Year: 2007
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Effective patient compliance on nasal continuous positive airway pressure therapy supports an improvement in the quality of life in patients with obstructive sleep apnoea
Source: Eur Respir J 2003; 22: Suppl. 45, 96s
Year: 2003
Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Twenty years compliance with continuous positive air pressure treatment in patients with severe obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept